Heparin will just attempt to break up the clot and heparin agents do agents have some anti-inflammatory properties but not in the same league as MSCs. Like taking a knife to a gun fight.
Again, would be better to prevent the on-going damage which continues to spread through more organs, with more micro-emboli developing, which themselves are pro-inflammatory, by using MSCs. Makes sense to me.
Patients who are bed-bound are usually given DVT prophylaxis in any case, and can go from there to full anti-coagulation, which is considered on a case by case basis, but some Covid cases may be at risk of bleeding (perhaps counter-intuitively) complicating their management. So again, stop the clotting problem at its source (inflammation) with MSCs and you avoid potentially life threatening clotting vs treatment-related bleeding.
This dilemma occurs in treating cancer and in treating pre-eclampsia (an inflammatory condition associated with pregnancy), so we are used to the balancing act. If it can be avoided, eg now with MSCs in this condition (Covid-19/ARDS) that would be a game-changer, and most welcome. IMO.
- Forums
- ASX - By Stock
- Chances of Covid Trial being a success
Heparin will just attempt to break up the clot and heparin...
-
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LGP
Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B |
Open | High | Low | Value | Volume |
$1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | $1.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.46 | 27045 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | 1.450 |
2 | 5794 | 1.445 |
6 | 50901 | 1.440 |
4 | 52442 | 1.435 |
5 | 177906 | 1.430 |
Price($) | Vol. | No. |
---|---|---|
1.455 | 27045 | 2 |
1.460 | 64331 | 5 |
1.465 | 35901 | 2 |
1.470 | 54504 | 2 |
1.480 | 132521 | 3 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |